4.5 Article

Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT)

Journal

LUNG CANCER
Volume 69, Issue 1, Pages 77-85

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.lungcan.2009.09.006

Keywords

Lung cancer; Stage I; Stereotactic radiation therapy; Radiation injury; Computed tomography; Radiation fibrosis

Ask authors/readers for more resources

Objective: To describe early and late CT patterns of radiographic lung injury after SBRT for lung cancer, and to correlate radiological findings with patient and treatment characteristics. Materials and methods: Follow-up CT scans of 68 patients with 70 tumors were divided into 4 periods: (1) 6 weeks; (2) 2-6 months; (3) 7-12 months and (4) 13-18 months after SBRT. Early (within 6 months) and late radiological injuries were evaluated according to Ikezoe and Koening, respectively. The correlation between CT findings and patient characteristics was evaluated. Results: Radiographic injury in periods 1 and 2 was: (1) diffuse consolidation 3 and 27%, (2) patchy consolidation and ground-glass opacity (GGO) 13.2 and 33%, (3) diffuse GGO 13.2 and 21%, (4) patchy GGO 16.2 and 6%, and (5) no findings 54.4 and 21%, respectively. Late injury in periods 3 and 4 were: (1) modified conventional pattern (consolidation, volume loss, bronchiectasis) 54 and 44%, (2) mass-like 20 and 28%, (3) scar-like 14 and 16% and (4) no findings 20 and 12%, respectively. The proportion of emphysema grades 2-4 was significantly higher in patients who had no radiological findings 6 weeks after treatment (p = 0.021). Both patchy consolidation and GGO patterns resulted more frequently in patients who were not administered steroids (p = 0.035). No relationship was found with smoking, tumor dimension and radiation dose. Conclusions: The majority of patients had no evidence of radiographic lung injury 6 weeks after SBRT; the most prevalent findings were diffuse or patchy GGO. Patchy and diffuse consolidation develops 2-6 months after SBRT. Modified conventional pattern was the most prevalent in the late periods. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group

John A. Vargo, Vitali Moiseenko, Jimm Grimm, Jimmy Caudell, David A. Clump, Ellen Yorke, Jinyu Xue, Yevgeniy Vinogradskiy, Eduardo G. Moros, Panayiotis Mavroidis, Sheena Jain, Issam El Naqa, Lawrence B. Marks, Dwight E. Heron

Summary: This study systematically reviewed the available literature on tumor control probability with SBRT in head and neck cancer patients, finding a dose-response relationship suggesting better local control and possibly improved overall survival with doses of 35 to 45 Gy (in 5 fractions) compared with <30 Gy. It is suggested that SBRT doses equivalent to 5-fraction doses of 40 to 50 Gy are used for retreatment.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways

Michael T. Milano, Jimm Grimm, Scott G. Soltys, Ellen Yorke, Vitali Moiseenko, Wolfgang A. Tome, Arjun Sahgal, Jinyu Xue, Lijun Ma, Timothy D. Solberg, John P. Kirkpatrick, Louis S. Constine, John C. Flickinger, Lawrence B. Marks, Issam El Naqa

Summary: This study analyzed dosimetric and clinical predictors of radiation-induced optic nerve/chiasm neuropathy after single-fraction stereotactic radiosurgery or hypofractionated radiosurgery. The results showed that the maximum point dose to the optic apparatus was related to RION risk, providing insight into NTCP risks.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities

Ariel E. Marciscano, Adriana Haimovitz-Friedman, Percy Lee, Phuoc T. Tran, Wolfgang A. Tome, Chandan Guha, Feng-Ming (Spring) Kong, Arjun Sahgal, Issam El Naqa, Andreas Rimner, Lawrence B. Marks, Silvia C. Formenti, Theodore L. DeWeese

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer

Percy Lee, Billy W. Loo Jr, Tithi Biswas, George X. Ding, Issam M. El Naqa, Andrew Jackson, Feng-Ming Kong, Tamara LaCouture, Moyed Miften, Timothy Solberg, Wolfgang A. Tome, An Tai, Ellen Yorke, X. Allen Li

Summary: Based on the evaluation of published experiences with SBRT, a steep dose-response relationship exists with high rates of durable local control for early-stage non-small cell lung cancer when physical doses of 43-50 Gy are delivered.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Quantum-inspired algorithm for radiotherapy planning optimization

Julia M. Pakela, Huan-Hsin Tseng, Martha M. Matuszak, Randall K. Ten Haken, Daniel L. McShan, Issam El Naqa

MEDICAL PHYSICS (2020)

Review Oncology

Oncology Informatics: Status Quo and Outlook

Paul Martin Putora, Michael Baudis, Beth M. Beadle, Issam El Naqa, Frank A. Giordano, Nils H. Nicolay

ONCOLOGY (2020)

Editorial Material Oncology

Prospective clinical deployment of machine learning in radiation oncology

Issam El Naga

Summary: Artificial intelligence and machine learning have the potential to improve cancer care accessibility, efficiency, cost-effectiveness, and personalization, but carefully planned deployment strategies are needed to validate their performance in real-world clinical settings and overcome the trust barrier.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Engineering, Biomedical

Dynamic stochastic deep learning approaches for predicting geometric changes in head and neck cancer

Julia M. Pakela, Martha M. Matuszak, Randall K. Ten Haken, Daniel L. McShan, Issam El Naqa

Summary: The study investigates the feasibility of predicting patient anatomical changes using two different methods during fractionated treatment, and results show that the MRNN framework performs slightly better than the QRNN framework on a dataset of 125 head and neck cancer patients.

PHYSICS IN MEDICINE AND BIOLOGY (2021)

Article Oncology

Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy

Ibrahim Chamseddine, Yejin Kim, Brian De, Issam El Naqa, Dan G. Duda, John Wolfgang, Jennifer Pursley, Harald Paganetti, Jennifer Wo, Theodore Hong, Eugene J. Koay, Clemens Grassberger

Summary: This study developed machine learning models to predict treatment failure and radiation-induced toxicities in patients with hepatocellular carcinoma after radiotherapy. The models demonstrated excellent performance, particularly in high-risk patients, and could be used for patient stratification and treatment selection.

JCO CLINICAL CANCER INFORMATICS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Advanced Topics in Particle Radiotherapy

Kyung-Wook Jee, Thomas Bortfeld, Issam El Naqa, Lei Dong

Summary: This special issue collects and presents research and developmental works in the forefront of particle radiotherapy (pRT) investigations. It focuses on seven subfields that represent recent advances in medical physics communities, including ultrahigh dose rate (FLASH) particle therapy, online adaptive particle therapy, MR-particle RT systems, compact, affordable, and accessible particle RT systems, range uncertainty reduction, range verification, and artificial intelligence in particle therapy. The editorial provides visionary perspectives on each subfield's present activities and future research directions, along with a synopsis of the published articles pertaining to each subfield.

IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES (2022)

Article Computer Science, Interdisciplinary Applications

Precision radiotherapy via information integration of expert human knowledge and AI recommendation to optimize clinical decision making

Wenbo Sun, Dipesh Niraula, Issam El Naqa, Randall K. Ten Haken, Ivo Dinov, Kyle Cuneo, Judy (Jionghua) Jin

Summary: This paper presents a systematic method to integrate expert human knowledge with AI recommendations for optimizing clinical decision making. It combines Gaussian process models with deep neural networks to quantify the uncertainty of treatment outcomes given by physicians and AI recommendations, providing guidance for clinical physicians and improving AI models performance.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2022)

Article Engineering, Biomedical

MIDRC CRP10 AI interface-an integrated tool for exploring, testing and visualization of AI models

Naveena Gorre, Eduardo Carranza, Jordan Fuhrman, Hui Li, Ravi K. Madduri, Maryellen Giger, Issam El Naqa

Summary: The objective of this study is to develop a modular and user-friendly software tool for clinical applications of machine learning models. This tool allows clinicians, researchers, and early AI developers to explore, train, and test AI algorithms, and provides visualization and interpretability of otherwise blackbox AI algorithms.

PHYSICS IN MEDICINE AND BIOLOGY (2023)

Article Oncology

The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors

Islam Eljilany, Payman Ghasemi Saghand, James Chen, Aakrosh Ratan, Martin McCarter, John Carpten, Howard Colman, Alexandra P. Ikeguchi, Igor Puzanov, Susanne Arnold, Michelle Churchman, Patrick Hwu, Jose Conejo-Garcia, William S. Dalton, George J. Weiner, Issam M. El Naqa, Ahmad A. Tarhini

Summary: In this study, the prognostic value of immunoscore calculated from real-world transcriptomic data was evaluated in patients with advanced malignancies treated with immune checkpoint inhibitors. The results demonstrated that the immunoscore could predict patients at risk of death, with better overall survival observed in patients with intermediate-high immunoscore.

CANCERS (2023)

Review Oncology

Overview of approaches to estimate real-world disease progression in lung cancer

Rossybelle Amorrortu, Melany Garcia, Yayi Zhao, Issam El Naqa, Yoganand Balagurunathan, Dung-Tsa Chen, Thanh Thieu, Matthew B. Schabath, Dana E. Rollison

Summary: This narrative review summarizes existing literature on approaches to estimate real-world disease progression in lung cancer patients. Five approaches were identified, including manual abstraction, natural language processing, treatment-based algorithms, changes in tumor volume, and delta radiomics-based approaches. The accuracy of these approaches was assessed using different methods.

JNCI CANCER SPECTRUM (2023)

Article Oncology

Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular Carcinoma

Mark Farha, Neil K. Jairath, Theodore S. Lawrence, Issam El Naqa

JCO CLINICAL CANCER INFORMATICS (2020)

No Data Available